COMP <GO>
VRSN vs CTSH // FORWARD P/E MULTIPLE
VeriSign Inc. (NASDAQ) VS. Cognizant Technology Solutions Corporation (NASDAQ) • 15-METRIC TALLY: VRSN 5
— CTSH 7
▲ FORWARD P/E MULTIPLE LEADER: CTSH
LAST: $305.95 (-0.34%) • MKT CAP: $27.44B
forward-pe
30.9x
LAST: $62.52 (-5.79%) • MKT CAP: $28.16B
forward-pe
11.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VRSN VS. CTSH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VRSN | CTSH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.30% | 19.60% | +20.70 | VRSN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.1x | 7.4x | +17.70 | CTSH | /valuation <GO> |
| Free Cash Flow Yield | 3.89% | 9.21% | -5.32 | CTSH | /fcf-yield <GO> |
| Operating Margin | 67.70% | 16.10% | +51.60 | VRSN | /operating-margins <GO> |
| Net Profit Margin | 49.80% | 10.60% | +39.20 | VRSN | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 7.00% | -0.60 | CTSH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.78% | 2.17% | -1.39 | CTSH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.80 | -5.35 | CTSH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 47.1 | +9.50 | VRSN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.21 | 1.16 | +0.05 | VRSN | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 30.9x | 11.7x | +19.20 | CTSH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.44B | $28.16B | -$718.1M | CTSH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VRSN REV | CTSH REV | VRSN GROSS % | CTSH GROSS % | VRSN FCF | CTSH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.66B | $21.11B | 88.2% | — | $1.07B | $2.60B |
| FY 2024 | $1.56B | $19.74B | 87.7% | — | $874.5M | $1.83B |
| FY 2023 | $1.49B | $19.35B | — | — | $786.6M | $1.46B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VRSN // BETA 1.21
CTSH // BETA 1.16